Poly-ADP ribose polymerase (PARP) inhibitor regimens for platinum-sensitive ovarian cancer in randomized, double-blind, phase III controlled trials: protocol for a systematic review and network meta-analysis - Peng, Xiaolian; Liu, Jie (Frontiers in Medicine, 2025)